KAPRUKA

#ABUS to 4.91 Climbing to New Target by 16%

NASDAQ:ABUS   Arbutus Biopharma Corporation
Sector: Health Technology
Industry: Biotechnology

Arbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.


New Target : USD 4.91
Resistance 2 : USD 4.66
Resistance 1 : USD 4.42

Support 1 : USD 4.06
Support 2 : USD 3.82

**Disclaimer - This is not a financial advice, please trade with caution and on your own risk. This prediction Based on My Dreams.
Do not view this idea as a recommendation for trading or investing. Risk Only What You Can Afford. Always Use a Stop Loss. Past performance is not necessarily a guide to future performance.

I would appreciate your feedback on my analysis.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。